Despite modern advances in cancer diagnosis technology, the detection rate for invasive ovarian cancer is quite low, and the process is challenging, using a combination approach of transvaginal ultrasound and the serum cancer antigen-125 (CA-125) test. Here, MUC16 is linked to ovarian carcinoma.